Aigen Investment Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-17,745
Closed -$384K – 937
2025
Q3
$384K Buy
+17,745
New +$396K 0.06% 475
2024
Q1
– Sell
-7,923
Closed -$253K – 976
2023
Q4
$253K Sell
7,923
-11,955
-60% -$347K 0.05% 557
2023
Q3
$581K Buy
+19,878
New +$715K 0.11% 308
2020
Q4
– Sell
-14,848
Closed -$325K – 1016
2020
Q3
$325K Buy
+14,848
New +$264K 0.04% 509
2020
Q2
– Sell
-26,726
Closed -$175K – 1233
2020
Q1
$175K Buy
+26,726
New +$381K 0.02% 748

Other funds holding SGRY

Aigen Investment Management's SGRY Position: Q4 2025 in Review

Aigen Investment Management sold out of Surgery Partners (SGRY) in Q4 2025, closing a stake of 17,745 shares — an estimated $384K sold.

Aigen Investment Management first reported a position in SGRY in Q1 2020 and held it in 5 quarters. The position peaked at $581K in Q3 2023. 181 funds tracked by Wall St. Rank hold SGRY as of Q4 2025.

  • Aigen Investment Management reported no remaining Surgery Partners position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 17,745 Surgery Partners shares in Q4 2025, an estimated $384K.
  • Aigen Investment Management first reported a position in Surgery Partners in Q1 2020 and held it in 5 quarters.
  • Aigen Investment Management's Surgery Partners position peaked at $581K in Q3 2023.
  • 181 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.